Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Compass Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +5 vs. Q2 2022
- Shares held
- 63.9M
- +1.98M (+3.2%) vs. Q2 2022
- Total value
- $145.6M
- −$18.3M (−11.1%) vs. Q2 2022
- New holders
- 9
- 11 more added
- Sold out
- 4
- 3 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $528.7M |
| Q2 2025 | 103 | $281.5M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.6M |
| Q2 2024 | 82 | $93.4M |
| Q1 2024 | 78 | $187.2M |
| Q4 2023 | 77 | $134.3M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $266.5M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $145.6M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 457 | $1.00K | 0.00% | +457 | New |
| Barclays PLC | 374 | $1.00K | 0.00% | +374 | New |
| Royal Bank of Canada | 675 | $2.00K | 0.00% | +447+196.1% | Added |
| Citigroup Inc | 4,533 | $10.0K | 0.00% | +3,163+230.9% | Added |
| UBS Group AG | 7,228 | $16.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,872 | $20.0K | 0.00% | +8,259+1,347.3% | Added |
| Flagship Harbor Advisors, LLC | 14,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 14,265 | $33.0K | 0.00% | +14,265 | New |
| Susquehanna International Group, LLP | 19,738 | $45.0K | 0.00% | +19,738 | New |
| New Capital Management LP | 24,243 | $55.0K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 24,251 | $55.0K | 0.00% | +24,251 | New |
| Salem Investment Counselors Inc | 30,000 | $68.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 31,736 | $73.0K | 0.00% | +31,736 | New |
| Marshall Wace, LLP | 51,816 | $117.0K | 0.00% | +28,089+118.4% | Added |
| Millennium Management LLC | 63,187 | $144.0K | 0.00% | +35,326+126.8% | Added |
| Renaissance Technologies LLC | 64,215 | $146.0K | 0.00% | −1,950−2.9% | Reduced |
| Northern Trust Corp | 87,367 | $199.0K | 0.00% | +87,367 | New |
| LMR Partners LLP | 100,000 | $228.0K | 0.01% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 188,094 | $429.0K | 0.12% | −10,000−5.0% | Reduced |
| Silverarc Capital Management, LLC | 262,090 | $598.0K | 0.25% | +262,090 | New |
| Geode Capital Management, LLC | 601,324 | $1.37M | 0.00% | +576,467+2,319.1% | Added |
| Fred Alger Management, LLC | 608,536 | $1.39M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 872,497 | $1.99M | 0.00% | +709,071+433.9% | Added |
| Eventide Asset Management, LLC | 1,100,399 | $2.51M | 0.05% | +1,100,399 | New |
| Monashee Investment Management LLC | 1,230,441 | $2.81M | 1.04% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,505,738 | $3.43M | 0.01% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 1,554,250 | $3.54M | 10.64% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,000,000 | $4.56M | 0.50% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $4.56M | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,380,623 | $5.43M | 0.00% | +878,650+58.5% | Added |
| CHI Advisors LLC | 2,829,712 | $6.45M | 1.73% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,522,980 | $8.07M | 0.01% | +175,809+5.3% | Added |
| Foresite Capital Management V, LLC | 4,400,000 | $10.0M | 7.71% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,606,600 | $10.5M | 0.03% | +200,000+4.5% | Added |
| Rock Springs Capital Management LP | 5,333,188 | $12.2M | 0.31% | +5,100+0.1% | Added |
| FMR LLC | 6,354,814 | $14.5M | 0.00% | −517,600−7.5% | Reduced |
| OrbiMed Advisors LLC | 21,960,850 | $50.1M | 1.00% | 00.0% | Unchanged |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −1,603,789−100.0% | Sold out |
| CM Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −15,682−100.0% | Sold out |
| Charter Oak Capital Management, LLC | 0 | $0 | 0.00% | −1,483−100.0% | Sold out |
| B. Riley Wealth Management, Inc. | – | – | – | – | Not filed |